Nantahala Capital Management, LLC Reports 15.1% Passive Stake in Eagle Pharmaceuticals Inc as of June 30- SEC Filing
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.